Hester Biosciences Limited (BOM:524669)
1,699.95
+33.00 (1.98%)
At close: Apr 28, 2026
Hester Biosciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 14,461 | 10,667 | 11,818 | 12,934 | 23,099 | 16,306 | Upgrade
|
| Market Cap Growth | -4.37% | -9.74% | -8.63% | -44.00% | 41.66% | 107.20% | Upgrade
|
| Enterprise Value | 16,649 | 13,063 | 14,503 | 15,490 | 24,167 | 17,452 | Upgrade
|
| Last Close Price | 1699.95 | 1249.57 | 1381.11 | 1504.56 | 2675.03 | 1880.37 | Upgrade
|
| PE Ratio | 35.54 | 38.81 | 62.57 | 48.58 | 58.75 | 47.36 | Upgrade
|
| PS Ratio | 4.58 | 3.41 | 3.80 | 4.65 | 9.37 | 7.49 | Upgrade
|
| PB Ratio | 4.12 | 3.27 | 3.90 | 4.48 | 8.64 | 6.91 | Upgrade
|
| P/TBV Ratio | 4.38 | 3.47 | 4.11 | 4.67 | 8.96 | 7.17 | Upgrade
|
| P/FCF Ratio | - | 24.29 | 49.69 | - | - | 94.19 | Upgrade
|
| P/OCF Ratio | - | 16.54 | 24.53 | 54.82 | 265.14 | 28.09 | Upgrade
|
| EV/Sales Ratio | 5.27 | 4.18 | 4.66 | 5.57 | 9.80 | 8.02 | Upgrade
|
| EV/EBITDA Ratio | 21.39 | 21.06 | 24.17 | 24.81 | 33.90 | 24.23 | Upgrade
|
| EV/EBIT Ratio | 27.05 | 28.63 | 33.63 | 36.86 | 43.91 | 29.52 | Upgrade
|
| EV/FCF Ratio | - | 29.74 | 60.97 | - | - | 100.81 | Upgrade
|
| Debt / Equity Ratio | 0.61 | 0.69 | 0.85 | 0.95 | 0.85 | 0.47 | Upgrade
|
| Debt / EBITDA Ratio | 2.97 | 3.59 | 4.28 | 4.38 | 3.19 | 1.52 | Upgrade
|
| Debt / FCF Ratio | - | 5.09 | 10.84 | - | - | 6.36 | Upgrade
|
| Net Debt / Equity Ratio | 0.59 | 0.66 | 0.80 | 0.90 | 0.76 | 0.38 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.86 | 3.49 | 4.04 | 4.16 | 2.85 | 1.23 | Upgrade
|
| Net Debt / FCF Ratio | - | 4.93 | 10.19 | -4.79 | -2.33 | 5.13 | Upgrade
|
| Asset Turnover | - | 0.48 | 0.47 | 0.45 | 0.51 | 0.55 | Upgrade
|
| Inventory Turnover | - | 1.27 | 1.24 | 1.03 | 0.99 | 0.84 | Upgrade
|
| Quick Ratio | - | 0.70 | 0.95 | 0.68 | 0.85 | 1.15 | Upgrade
|
| Current Ratio | - | 1.56 | 2.04 | 1.53 | 2.01 | 2.63 | Upgrade
|
| Return on Equity (ROE) | - | 9.16% | 7.16% | 10.09% | 15.69% | 15.68% | Upgrade
|
| Return on Assets (ROA) | - | 4.33% | 4.05% | 4.26% | 7.07% | 9.26% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.80% | 6.11% | 5.23% | 5.76% | 10.22% | 12.93% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 8.60% | 7.70% | 8.10% | 11.80% | 16.90% | Upgrade
|
| Earnings Yield | 2.83% | 2.58% | 1.60% | 2.06% | 1.70% | 2.11% | Upgrade
|
| FCF Yield | - | 4.12% | 2.01% | -4.19% | -3.77% | 1.06% | Upgrade
|
| Dividend Yield | 0.41% | 0.56% | 0.43% | 0.53% | 0.37% | 0.53% | Upgrade
|
| Payout Ratio | - | 18.80% | 36.28% | 31.95% | 21.63% | 16.31% | Upgrade
|
| Total Shareholder Return | 1.00% | 0.56% | 0.43% | 0.53% | 0.37% | 0.53% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.